Search clinical trials for: Atherosclerotic Cardiovascular Disease (ASCVD)

Total 382216 results

National Cheng-Kung University Hospital

Unknown

Artificial Intelligence With Deep Learning and Genes on Cardiovascular Disease

Cardiovascular Diseases

Taiwan
Academic Centre for Dentistry in Amsterdam
Labonovum B.V.; Sunstar Suisse S.A.; Netherlands Enterprise Agency

Completed

Periodontitis as Signal for an Underlying Disease (PACMEL)

Cardiovascular Diseases | Obstructive Sleep Apnea Syndrome | Diabetes Mellitus | Periodontal Diseases

Netherlands
Second Affiliated Hospital, School of Medicine,...

Active, not recruiting

Prospective Cohort Study of Panvascular Disease

ASCVD

China
Duke University
Janssen Scientific Affairs, LLC

Completed

The Learning Registry

Atherosclerotic Cardiovascular Disease

United States
Assiut University

Unknown

Association Between Dietary Habits and Risk Factors for Atherosclerotic Cardiovascular Diseases in Assiut Governorate

Atherosclerotic Cardiovascular Disease
Amgen
Duke Clinical Research Institute

Terminated

The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) (cvMOBIUS)

ASCVD

United States, Canada
Xiang Xie
Xinjiang Medical University

Not yet recruiting

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

Cancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

Taiwan, United States, Spain, Argentina, China, Italy, Australia, France, Canada, Japan, Belgium, Denmark, Germany, Hungary, Israel, Austria, Korea, Republic of, Brazil, Mexico, Netherlands, Romania, United Kingdom, Greece, Czechia, India, Slovak... and more
Novo Nordisk A/S

Completed

A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants

Healthy Volunteers | Elevated Cholesterol | Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk

Germany
The Medicines Company

Completed

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol (ORION-10)

Elevated Cholesterol | ASCVD

United States
Assiut University

Not yet recruiting

10 Years Cardiovascular Risk Score Among Primary Health Care Centre Attendees, Assiut Governorate.

Cardiovascular Risk Score
Cedars-Sinai Medical Center

Active, not recruiting

Beauty From Within Community Screening Project (BFW)

Heart Health Screening and Prevention

United States
Advanced Education & Research Center
University of Karachi; Pakistan Cardiac Society (Heart House)

Recruiting

Prospective Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk

Atherosclerotic Cardiovascular Diseases (ASCVD)

Pakistan
Yan Bi

Recruiting

Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease

Machine Learning | Non-Alcoholic Fatty Liver Disease

China
Yuhan Corporation

Completed

High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

ASCVD

Korea, Republic of
Stanford University

Not yet recruiting

Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD) (NOTIFY-ASCVD)

Coronary Artery Calcification | ASCVD
Yonsei University

Recruiting

Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

Atherosclerotic Cardiovascular Disease

Korea, Republic of
The Medicines Company

Completed

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol (ORION-11)

Risk Factor, Cardiovascular | Elevated Cholesterol | ASCVD

Germany, Czechia, Hungary, Poland, South Africa, Ukraine, United Kingdom
Yuhan Corporation

Unknown

High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes

Type 2 Diabetes | Atherosclerotic Cardiovascular Disease

Korea, Republic of
Yuhan Corporation

Completed

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Hypertension | Impaired Fasting Glucose | ASCVD

Korea, Republic of
Amgen

Completed

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Dyslipidemia | Medical Conditions to be Studied | ASCVD Management

United States
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Hypercholesterolemia

China, Taiwan, Korea, Republic of, Singapore
Amgen
Organization of Teratology Information Specialists (OTIS) Research Center...

Terminated

Evolocumab Pregnancy Exposure Registry

Hypercholesterolemia; ASCVD; Pregnancy
Samsung Medical Center

Recruiting

Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD (CVD_OBS)

Cardiovascular Diseases | Atherosclerosis | Pregnancy Complications | Adverse Cardiac Event | Adverse Birth Outcomes

Korea, Republic of
Novartis Pharmaceuticals

Recruiting

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Hypercholesterolemia

Germany
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
Organon and Co
Iqvia Pty Ltd

Recruiting

Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

Atherosclerotic Cardiovascular Disease

Korea, Republic of
Novartis Pharmaceuticals

Completed

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C (ORION-8)

Elevated Cholesterol | Homozygous Familial Hypercholesterolemia | Heterozygous Familial Hypercholesterolemia | ASCVD

United States, Canada, Czechia, Denmark, Germany, Hungary, Netherlands, Poland, South Africa, Spain, Sweden, Ukraine, United Kingdom
Shanghai 10th People's Hospital

Recruiting

Metabolomics Characterization of Biomarkers of ASCVD and Prediction Model (MEAL)

Atherosclerosis | Prediction Model

China
Aalborg University Hospital
Danish Heart Foundation

Completed

Alpha-linolenic Acid and the Risk of ASCVD

Ischemic Stroke | Peripheral Artery Disease | Acute Myocardial Infarction
Ain Shams University

Recruiting

Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias

Egypt
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
Assiut University

Unknown

Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases
The Hong Kong Polytechnic University

Not yet recruiting

Effects of Integrated Cardiovascular Health Education Program on Older Adults at Risk of ASCVD

Cardiovascular Diseases | Health Education | Healthy Lifestyle

Hong Kong
Yuhan Corporation

Completed

Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM (MIRA)

Type 2 Diabetes Mellitus | Atherosclerotic Cardiovascular Disease

Korea, Republic of
Novartis Pharmaceuticals

Recruiting

The Belgian REAL (BE.REAL) Registry (BE REAL)

Atherosclerotic Cardiovascular Disease

Belgium
The Hong Kong Polytechnic University

Not yet recruiting

Effects of Cardiovascular Health Education Program on Community-dwelling Older Adults at Risk of ASCVD

Cardiovascular Diseases | Health Education | Healthy Lifestyle
China National Center for Cardiovascular Diseases

Recruiting

LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)

Atherosclerotic Cardiovascular Disease | LDL Cholesterol | Older Patients

China
Esperion Therapeutics, Inc.

Completed

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk (CLEAR Wisdom)

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

United States
Shaochun.Li
Beijing Friendship Hospital; Peking University Third Hospital; Xuanwu Hospital... and other collaborators

Unknown

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

Dyslipidemia | Subclinical hypothyroïdism | ASCVD | Statin

China
Tungs' Taichung Metroharbour Hospital

Completed

Serum Level of Lipopolysaccharide-binding Protein (LBP) and Atherosclerosis in Hemodialysis Patients

Systemic Inflammatory Response Syndrome

Taiwan
Esperion Therapeutics, Inc.

Completed

Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

United States
Esperion Therapeutics, Inc.

Completed

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Hypercholesterolemia | Atherosclerotic Cardiovascular Diseases

United States, United Kingdom, Germany, Poland, Netherlands, Canada
Zhejiang Provincial People's Hospital
Ningbo Medical Center Lihuili Hospital; Red Cross Hospital, Hangzhou, China; The... and other collaborators

Not yet recruiting

Observational Study of ASCVD Risks of Type 2 Diabetes in East China

Type 2 Diabetes Mellitus | Liraglutide | Arteriosclerotic Cardiovascular Disease
Novartis Pharmaceuticals

Completed

A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) (V-INITIATE)

Atherosclerotic Cardiovascular Disease

United States
Esperion Therapeutics, Inc.

Completed

A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

Hyperlipidemias

United States
Indiana University
Pfizer; National Comprehensive Cancer Network; Myovant Sciences GmbH

Recruiting

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Prostate Cancer

United States
Seung-Whan Lee, M.D., Ph.D.
Yuhan Corporation

Recruiting

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

Pre Diabetes | ASCVD

Korea, Republic of
Esperion Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant (CLEAR Serenity)

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease | Statin Adverse Reaction

United States, Canada
Novartis Pharmaceuticals

Not yet recruiting

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

3

Subscribe